Spasmolytic effects of pyrazolone drugs.
作者信息
Forth W
出版信息
Agents Actions Suppl. 1986;19:169-75.
PMID:3463175
Abstract
摘要
相似文献
1
Spasmolytic effects of pyrazolone drugs.
Agents Actions Suppl. 1986;19:169-75.
2
[The pyrazolones].
Pract Odontol. 1990 Sep;11(9):72-3.
3
The effect of intravenously administered Palerol and Litalgin on the contraction of the human gallbladder.
Int J Clin Pharmacol Ther Toxicol. 1981 May;19(5):206-8.
4
Inhibition of human neutrophil oxidative burst by pyrazolone derivatives.
Free Radic Biol Med. 2006 Feb 15;40(4):632-40. doi: 10.1016/j.freeradbiomed.2005.09.017. Epub 2005 Oct 21.
5
Pyrazolone derivatives.
Drugs. 1986;32 Suppl 4:60-70. doi: 10.2165/00003495-198600324-00006.
6
[Animal experimental study on spasmolytic and analgesic activities of pramiverine, metamizole and their combination (author's transl)].
Arzneimittelforschung. 1976 Apr;26(4b):696-8.
7
Investigation of rociverine + dipyrone for antispasmodic and analgesic interactions.
Arzneimittelforschung. 1979;29(5):760-5.
8
[Regulation of labor activity with a spasmoanalgesic agent, baralgin].
Vopr Okhr Materin Det. 1978 Oct;23(10):67-9.
9
10
The analgesic effects of the decomposition products of sulpyrine, N-[2-(5-hydroxymethyl-2,3,4,5-tetrahydro-2,3,4-trihydroxy)furyl]methyl-N-methylantipyrine and Antipyrinyl-4-peroxide.
Chem Pharm Bull (Tokyo). 1981 Apr;29(4):1179-81. doi: 10.1248/cpb.29.1179.
引用本文的文献
1
Effects of dipyrone on the digestive tract.
Braz J Med Biol Res. 2019 Jan 10;52(2):e8103. doi: 10.1590/1414-431X20188103.
Zotero 插件